CC2019: Vulnerable Elderly: Optimizing Care for the Frail Patient (GER)
This session has been identified and designated as Credit to Address Regulatory Mandate for Geriatric. Learn more about state regulatory mandates.
In recent years, more has been learned about the definition of frailty and novel interventions to minimize frailty and its effects have been focused on improving outcomes for these vulnerable patients. This session will discuss: the surgical models of accelerated frailty; what we have learned from transplant patients about frailty; preventive measures for postoperative complications due to frailty; and implementing a focused program for our patients: The Coalition of Quality for Geriatric Surgery (COGS).
Moderator: Michael E. Zenilman, MD, FACS, Brooklyn, NY
Co-Moderator: Rachel G. Khadaroo, MD, PhD, FRCSC, FACS, Edmonton, Alberta
Introduction to Session
Michael E. Zenilman, MD, FACS, Brooklyn, NY
Introduction to Speakers
Rachel G. Khadaroo, MD, PhD, FACS, FRCSC, Edmonton, Alberta
Definition: Surgical Models of Accelerated Frailty: What We Learned from Transplant Patients
Dorry L. Segev, MD, Baltimore, MD
Assessment: Quick Assessment and Prehabilitation
Rakesh C. Arora, MD, PhD, FACS, FRCSC, Winnipeg, Manitoba
Prevention: Frailty Programs in Surgical Care
Zara Cooper, MD, FACS, Boston, MA
The Future: The Coalition of Quality for Geriatric Surgery (COGS)
Ronnie A. Rosenthal, MD, FACS, West Haven, CT
Sponsored by the Scientific Forum Committee and the Task Force on Geriatric Surgery
- Practicing surgeons
- Apply new knowledge and ideas to improve their surgical practice
- Adapt concepts and quality measures in support of research advancements
- Enhance the quality of patient care
For questions about the course, please contact email@example.com.
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation.
(Download the full list of disclosures).
Faculty and Disclosures
Dorry L. Segev, MD, PhD, FACS - CSL behring: Honoraria: Speaking and advisory; Roche: Honoraria: Speaking and advisory; Novartis: Honoraria: Speaking and advisory; Sanofi: Honoraria: Speaking and advisory
Michael E. Zenilman MD, FACS - Nothing to Disclose
Rachel G. Khadaroo MD, PhD, FRCSC, FACS - Nothing to Disclose
Rakesh C. Arora, MD, PhD, FRCSC, FACS - Abbott Nutrition: Honoraria: Invited Advisory Board Member; Mallinckrodt Pharmaceuticals: Honoraria: Invited Advisory Board Member; Pfizer Canada Inc.: Grant: Principal Investigator
Ronnie A. Rosenthal MD, FACS - Nothing to Disclose
Zara Cooper MD, MSc, FACS - Nothing to Disclose
Program Committee and Disclosures
CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - Nothing to Disclosure
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - Nothing to Disclosure
David C. Borgstrom, MD, FACS, Morgantown, WV - Nothing to Disclosure
Daniel L. Dent, MD, FACS, San Antonio, TX - Nothing to Disclosure
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Cynthia D. Downard, MD, FACS, Louisville, KY - Nothing to Disclosure
Audra A. Duncan, MD, FACS, London, ON - Nothing to Disclosure
Mariam F. Eskander, MD, Boston, MA - Nothing to Disclosure
Paula Ferrada, MD, FACS, Richmond, VA - Nothing to Disclosure
Neil H. Hyman, MD, FACS, Chicago, IL - Nothing to Disclosure
Martin S. Karpeh, Jr., MD, FACS, New York, NY - Nothing to Disclosure
Dennis H. Kraus, MD, FACS, New York, NY - Nothing to Disclosure
Kenneth W. Sharp, MD, FACS, Nashville, TN - Nothing to Disclosure
Daniel M. Herron, MD, FACS, FASBMS, New York, NY - Nothing to Disclosure
Edith Tzeng, MD, FACS, Pittsburgh, PA - Nothing to Disclosure
Barbara Lee Bass, MD, FACS, FRCSEng(Hon), FRCSI(Hon), FCOSECSA(Hon), Houston, TX - Nothing to Disclosure
Quan-Yang Duh, MD, FACS, San Francisco, CA - Nothing to Disclosure
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - Nothing to Disclosure
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - Nothing to Disclosure
Note: Residents will receive a Certificate of Completion.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Certificate of Completion
- 1.50 Self Assessment Credit